Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery

NCT01816035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

HER2/Neu Positive
Recurrent Breast Carcinoma
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer
Stage IV Breast Cancer

Interventions

OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
BIOLOGICAL: Trastuzumab Emtansine

Sponsor

University of Washington

Collaborators

[object Object]